(ARLP) Alliance Resource $1.03 EPS vs $0.93e.(ASTM) Aastrom Biosciences initiates adult stem cell clinical trial for Peripheral Arterial Disease.(BCE) BCE says it will finish its strategic review for...
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering...
Janney Montgomery Scott reiterated its Buy rating and $15 fair value estimate on Sangamo Biosciences as it brings multiple programs to the clinic this year.
Gene therapy may become the next frontier for drug companies seeking to make billions of dollars improving or even curing certain diseases.
If the collaboration between Sangamo and Kite Pharma works out, some investors might just ask why Gilead did not just acquire Sangamo.
This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here. Upgrades: > Dyne Therapeutics (DYN) upgraded to Strong Buy from...
Monday's additional top analyst upgrades and downgrades included BioMarin Pharmaceutical, Micron Technology, Quanta Services, Sangamo Therapeutics, Silvergate Capital, T. Rowe Price and Zendesk.
DJIA & S&P Futures down 0.4% to 0.5% on light trading activity as the US Dollar was very weak against the Euro (1.31) and the Yen. (AH) Armor Holdings positive article in Business Week.(ASX)...
Jefferies has picked out a few companies in the biotech industry that stand to win big over the coming year.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apollo Global, ADM, Celgene, Total, Whole Foods and Targa Resources.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Baker Hughes, Brocade Communications, CenturyLink, Chevron, Juniper Networks and National Oilwell Varco.
Investors and traders alike always seem to be on the lookout for new investment ideas. With the S&P 500 and the Dow Jones Industrial Average having recently hit new highs, 24/7 Wall St. decided...
Stocks tried to stabilize on Monday, and Tuesday’s early indications were for Dow and S&P 500 futures to be up almost 1%. Last week’s sell-off may have been the worst opening week for...
Thursday’s top analyst upgrades, downgrades and initiations include AK Steel, CVS Health, Micron Technology, Nike, Oracle, Pandora Media, Sunrun and US Steel.
Tuesday's top analyst upgrades and downgrades included Ambarella, Annaly Capital Management, Cinedigm, Fortinet, Kinder Morgan, 3M, Nikola, Nvidia, Tesla, Uber Technologies and YETI.